Keywords: merz, axura, shows, benefits, ad, data, demonstrating

Merz' Axura shows benefits in AD

Article | 12 July 2004

Data demonstrating significant benefits of German firm Merz' Alzheimer'sdisease drug Axura/Namenda (memantine) on both behavioral symptoms and functional capacities ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lundbeck

Go to company listing

Related Drugs

Memantine HCL

Namenda

Go to drug listing